Stay updated with breaking news from Oxford Nuffield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinicians should consider incorporating sodium-glucose cotransport 2 inhibitors into the management of acute kidney disease and type 2 diabetes, according to investigators. Research confirms the benefits of using sodium-glucose cotransport 2 inhibitors (SGLT2is) in patients with acute kidney disease.
Clinicians should consider incorporating sodium-glucose cotransport 2 inhibitors into the management of acute kidney disease and type 2 diabetes, according to investigators. Research confirms the benefits of using sodium-glucose cotransport 2 inhibitors (SGLT2is) in patients with acute kidney disease.
Several initiatives aimed to help those in need